Dalila Scaturro | Biological Networks | Best Researcher Award

Best Researcher Award

Dalila Scaturro
Università degli Studi di Palermo, Italy

Dalila Scaturro
Affiliation Università degli Studi di Palermo
Country Italy
Scopus ID 56156164000
Documents 56
Citations 665
h-index 15
Subject Area Biological Networks
Event International Research Awards on Network Science & Graph Analytics
ORCID 0000-0002-5035-2288

Dalila Scaturro is an Italian researcher affiliated with the Università degli Studi di Palermo whose scholarly activities encompass rehabilitation medicine, musculoskeletal disorders, peripheral neuropathies, and interdisciplinary biomedical research. Her publication portfolio demonstrates sustained engagement with evidence-based rehabilitation approaches and clinical outcomes assessment. Through collaborative research efforts, she has contributed to studies addressing pain management, robotic-assisted orthopedic rehabilitation, systematic reviews, and rehabilitation sciences, supporting advancements in patient-centered healthcare and translational clinical practice.[1]

Abstract

This article summarizes the academic profile and research achievements of Dalila Scaturro. Her work is characterized by multidisciplinary collaboration across rehabilitation medicine, musculoskeletal health, orthopedic recovery, and neurological rehabilitation. Through clinical investigations and systematic reviews, she has contributed to the understanding of therapeutic interventions and rehabilitation outcomes while supporting evidence-based healthcare practices.[2]

Keywords

Rehabilitation Medicine, Biological Networks, Musculoskeletal Disorders, Clinical Research, Peripheral Neuropathies, Evidence-Based Healthcare, Orthopedic Rehabilitation, Systematic Reviews.

Introduction

Modern rehabilitation science increasingly relies on interdisciplinary collaboration and clinical evidence. Dalila Scaturro has participated in investigations examining rehabilitation outcomes, pain management strategies, and orthopedic interventions. Her scholarly record reflects a commitment to translating scientific findings into practical applications that may improve patient recovery and functional performance.[3]

Research Profile

With 56 indexed documents, 665 citations, and an h-index of 15, Scaturro has established a measurable scholarly presence within biomedical and rehabilitation research. Her publication record demonstrates engagement with clinical investigations, systematic reviews, and multidisciplinary healthcare studies. These metrics indicate sustained scientific productivity and visibility within her research community.[1]

Research Contributions

  • Investigation of exercise and mesotherapy approaches for neck pain associated with fibromyalgia.
  • Assessment of rehabilitation outcomes following robot-assisted total knee arthroplasty.
  • Contribution to systematic reviews on peripheral neuropathy rehabilitation and nerve repair.
  • Evaluation of intra-articular botulinum toxin interventions for knee osteoarthritis.
  • Research on scoliosis, body mass relationships, and musculoskeletal health outcomes.

Publications

  1. Neck pain in Fibromyalgia: treatment with exercise and mesotherapy. Biomedicines, 2023.
  2. Rehabilitation approach in robot assisted total knee arthroplasty: an observational study. BMC Musculoskeletal Disorders, 2023.
  3. The Role of Physical Exercise and Rehabilitative Implications in the Process of Nerve Repair in Peripheral Neuropathies: A Systematic Review. Diagnostics, 2023.
  4. Intra-Articular Injection of Botulinum Toxin for the Treatment of Knee Osteoarthritis. International Journal of Molecular Sciences, 2023.
  5. Is there relationship between idiopathic scoliosis and body mass? A scoping review. Nutrients, 2022.

Research Impact

The research contributions associated with Scaturro demonstrate relevance to clinical rehabilitation, musculoskeletal medicine, and healthcare outcomes. Her studies support evidence synthesis and clinical decision-making through observational research and systematic reviews. The citation record further indicates scholarly engagement with her published findings across related biomedical disciplines.[4]

Award Suitability

Dalila Scaturro’s publication output, citation performance, and collaborative research contributions align with the objectives of the International Research Awards on Network Science & Graph Analytics. Her multidisciplinary work demonstrates scientific rigor, sustained productivity, and contributions to healthcare knowledge dissemination. These characteristics support consideration for academic recognition within international research forums.[5]

Conclusion

Dalila Scaturro has developed a research portfolio focused on rehabilitation sciences, orthopedic recovery, and evidence-based clinical practice. Her scholarly activities, publication record, and measurable research impact illustrate continued engagement with contemporary biomedical challenges and support her standing within the academic community.[6]

References

  1. Elsevier. (n.d.). Scopus author details: Dalila Scaturro, Author ID 56156164000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56156164000
  2. Scaturro, D., et al. (2023). Neck pain in Fibromyalgia: treatment with exercise and mesotherapy. Biomedicines.
  3. Scaturro, D., et al. (2023). Rehabilitation approach in robot assisted total knee arthroplasty: an observational study. BMC Musculoskeletal Disorders.
  4. Chiaramonte, R., et al. (2023). The Role of Physical Exercise and Rehabilitative Implications in the Process of Nerve Repair in Peripheral Neuropathies. Diagnostics.
  5. Sconza, C., et al. (2023). Intra-Articular Injection of Botulinum Toxin for the Treatment of Knee Osteoarthritis. International Journal of Molecular Sciences.
  6. Scaturro, D., et al. (2022). Is there relationship between idiopathic scoliosis and body mass? A scoping review. Nutrients.

Probal Banerjee | Biological Network | Best Researcher Award

Dr. Probal Banerjee | Biological Network | Best Researcher Award

The College of Staten Island (City University of New York) | United States

Dr. Probal Banerjee is a distinguished biochemist and neuroscientist whose academic and research career spans over four decades of excellence in bioorganic chemistry, molecular neuroscience, and cancer research. He earned his B.Sc. in Chemistry (Hons) and M.Sc. in Organic Chemistry from Jadavpur University, Calcutta, followed by a Ph.D. in Bioorganic Chemistry from the Indian Institute of Science, Bangalore in 1984. He completed postdoctoral research at the University of Notre Dame in Biochemistry and Enzymology and at the University of Chicago in Molecular Neuroscience. Currently a Professor of Chemistry and Coordinator at the Center for Developmental Neuroscience, College of Staten Island, CUNY, Dr. Banerjee has made pioneering contributions to understanding neurodevelopmental signaling and immune-modulating cancer therapies. His numerous honors include the Children’s Research Foundation Grant (1989), Brain Research Foundation Award, and two Dolphin Awards for Academic Excellence and Teaching. A sought-after speaker, he has delivered invited lectures at leading institutions worldwide on topics ranging from serotonin signaling in brain development to multi-target cancer therapeutics. Dr. Banerjee is also an inventor with several patents on curcumin-based anticancer agents and therapeutic approaches for Fragile X Syndrome. His expertise is widely recognized through his service on multiple NIH grant review committees, reflecting his enduring impact on neuroscience, pharmacology, and translational cancer research.

Profiles: Orcid 

Featured Publications

"Novel Taxol-Derivative, STO-1, Induces Selective Anti-Tumor Immunity and Sustained Remission of Glioblastoma Without Triggering Autoimmune Reactions", Shubhasmita Mohapatra; Adrian Guerrero; Neha Rahman; Khondoker Takia Zaman; Jing Wu; Callistus Onyeagba; Chanyue Hu; Matteo Pellegrini; Jayaram Vankudoth; Seiya Kitamura et al., Cells, 2025.

"One-Pot Synthesis of Phenylboronic Acid-Based Microgels for Tunable Gate of Glucose-Responsive Insulin Release at Physiological pH", Prashun G. Roy; Jiangtao Zhang; Koushik Bhattacharya; Probal Banerjee; Jing Shen; Shuiqin Zhou, Molecules, 2025.

"Biocompatible Anisole-Nonlinear PEG Core–Shell Nanogels for High Loading Capacity, Excellent Stability, and Controlled Release of Curcumin", Jing Shen; Jiangtao Zhang; Weitai Wu; Probal Banerjee; Shuiqin Zhou, Gels 2023.

"The G Protein-Coupled Serotonin 1A Receptor Augments Protein Kinase Cε-Mediated Neurogenesis in Neonatal Mouse Hippocampus-PKCε-Mediated Signaling in the Early Hippocampus", Sreyashi Samaddar; Sudarshana Purkayastha; Souleymane Diallo; Subramanyam J. Tantry; Ryan Schroder; Pranavan Chanthrakumar; Michael J. Flory; Probal Banerjee, International Journal of Molecular Sciences 2022.

"Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells", Sumit Mukherjee; Angela Fried; Rahman Hussaini; Richard White; Juliet Baidoo; Sri Yalamanchi; Probal Banerjee, Journal of Experimental & Clinical Cancer Research, 2018.

Radim Vrzal | Molecular Biology | Best Researcher Award

Prof. Dr. Radim Vrzal | Molecular Biology | Best Researcher Award

Palacky University in Olomouc | Czech Republic

Author Profiles

Scopus

Orcid ID

Early Academic Pursuits

Prof. Dr. Radim Vrzal began his academic journey with a Master’s degree in Biochemistry from the Institute of Chemical Technology in Prague (1998–2003). His academic excellence and research aptitude led him to pursue a Ph.D. in cotutelle between Palacký University, Olomouc, and INSERM, Montpellier, France, where he investigated biochemical mechanisms under expert international guidance. This early exposure to collaborative research set the foundation for his future contributions in molecular biology, pharmacology, and toxicology.

Professional Endeavors

He commenced his professional career as an Assistant Professor at the Institute of Medical Chemistry and Biochemistry, Palacký University, in 2006. His teaching and research responsibilities later expanded at the Department of Cell Biology and Genetics, where he has served as an Associate Professor since 2011. Over the years, he has demonstrated excellence in pedagogy, supervising more than 40 students across bachelor’s, master’s, and Ph.D. levels, while consistently engaging in advanced teaching in hematology, human genetics, and toxicology.

Contributions and Research Focus

Prof. Vrzal’s research spans a wide spectrum of molecular and cellular biology, with a special emphasis on ligand-activated nuclear receptors, drug metabolism, cytotoxicity, and cellular signaling. His investigations into the biological activity of natural and synthetic compounds, post-translational modifications of nuclear receptors, and applications of human intestinal organoids mark his innovative approach to biomedical research. His ongoing work in prostate cancer and anticancer therapeutics highlights the translational value of his research.

Impact and Influence

With 99 publications indexed in WoS, over 1,600 citations (excluding self-citations), and an H-index of 25, Prof. Vrzal has established a solid academic presence. His work has significantly contributed to understanding receptor-mediated mechanisms and their pharmacological implications, influencing both academic discourse and applied therapeutic research. As a grant holder and collaborator, he has led and co-led several national and international projects, including studies on MAP kinases, CYP3A4 enzyme regulation, and synthetic tryptamine derivatives for cancer treatment.

Academic Citations

His research is widely cited, reflecting the global relevance of his work. The citation record underscores his contributions to advancing pharmacology and toxicology, where his insights have informed subsequent studies on drug metabolism and receptor signaling. This recognition also highlights his influence on shaping research directions in biochemical and biomedical sciences.

Legacy and Future Contributions

Prof. Vrzal’s legacy lies in his dual commitment to advancing scientific research and nurturing the next generation of scholars. His supervision of numerous students and his long-standing dedication to teaching ensure knowledge transfer and academic continuity. Looking forward, his ongoing projects on anticancer therapeutics and cellular models hold promise for impactful discoveries in medicine and pharmacotherapy.

Conclusion

Prof. Dr. Radim Vrzal exemplifies the qualities of a dedicated researcher, mentor, and innovator. His academic trajectory, impactful research contributions, and sustained influence in molecular and biomedical sciences position him as a deserving candidate for recognition. His ability to bridge fundamental science with applied therapeutic research ensures that his future work will continue to make meaningful contributions to both academia and society.

Notable Publications

“Skin-targeted AhR activation by microbial and synthetic indoles: Insights from the AhaRaCaT reporter cell

  • Author: Radim Vrzal; Aneta Grycová; Aneta Vrzalová
  • Journal: Toxicology Letters
  • Year: 2025

"‏Orchestra of ligand-activated transcription factors in the molecular symphony of SERPINE 1 / PAI-1 gene regulation

  • Author: Aneta Vrzalova; Radim Vrzal‏
  • Journal: Biochimie
  • Year: 2025

"Modulation of aryl hydrocarbon receptor activity by halogenated indoles

  • Author: Aneta Vrzalová; Radim Vrzal; Petr Nádvorník; Marek Šebela; Zdeněk Dvořák
  • Journal: Bioorganic and Medicinal Chemistry
  • Year: 2024

"Jasmone Is a Ligand-Selective Allosteric Antagonist of Aryl Hydrocarbon Receptor (AhR)

  • Author: Radim Vrzal; Adéla Marcalíková; Kristýna Krasulová; Lenka Zemánková; Zdeněk Dvořák‏
  • Journal: International Journal of Molecular Sciences‏
  • Year: 2023

"Monoterpenoid aryl hydrocarbon receptor allosteric antagonists protect against ultraviolet skin damage in female mice

  • Author: Karolína Ondrová; Iveta Zůvalová; Barbora Vyhlídalová; Kristýna Krasulová; Eva Miková; Radim Vrzal; Petr Nádvorník; Martina Kopečná; David Kopečný; Marek Šebela et al.
  • Journal: Nature Communications
  • Year: 2021